One study stratified 136 patients with resected NSCLC into 2 prognostic groups: group 1 (CD8+/PD-L1-negative) versus group 2 (CD8/PD-L1: positive/positive, negative/negative, and negative/positive). The gene discussed is CD274; the disease is non-small cell lung carcinoma.